Financials
- Market Capitalization 2.35 B
- Employee 34
- Founded 2011
- CEO N/A
- Website www.trevitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG003QGQRB9
- Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Related tickers
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 1885 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.71 USD | -1.52% | -5.65% | +32.81% | +102.59% | 2.36 B USD | ||
| 1887 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.62 USD | -1.10% | -9.21% | +59.75% | +540.61% | 2.35 B USD | ||
| 1898 | NKTR Nektar Therapeutics - Common Stock | 68.32 USD | -2.90% | -6.60% | +13.36% | -6.76% | 2.31 B USD | ||
| 1902 | PHVS Pharvaris N.V. - Ordinary Shares | 35.07 USD | 0.00% | +4.53% | +12.08% | +47.48% | 2.29 B USD |